Document is current

Any future updates will be listed below

Correction: Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)

Crossref DOI link: https://doi.org/10.1007/s10120-024-01570-x

Published Online: 2024-11-28

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark